OPZELURA 15 mg/g
ruxolitinib · CREAM · Incyte Corporation
No Recall History
Plain English
OPZELURA is a cream containing ruxolitinib at 15 mg/g, taken topical. Manufactured by Incyte Corporation.
Key Facts
- Brand Name
- OPZELURA
- Generic Name
- ruxolitinib
- NDC Code (Product)
50881-007- Manufacturer
- Incyte Corporation
- Strength
- 15 mg/g
- Dosage Form
- CREAM
- Route
- TOPICAL
- Marketing Status
- Application #
- NDA215309
- Marketing Start
- 09/21/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is OPZELURA used for?
OPZELURA contains ruxolitinib. It is a cream taken topical. Consult your doctor for specific uses.
Is OPZELURA a controlled substance?
OPZELURA is not classified as a controlled substance by the DEA.
What is the generic name for OPZELURA?
The generic name for OPZELURA is ruxolitinib. There are 10 other brand versions of ruxolitinib.
What is the NDC code for OPZELURA 15 mg/g?
The NDC (National Drug Code) for OPZELURA 15 mg/g is 50881-007, listed by Incyte Corporation.